- Motley Fool•4 hours ago
The move could pay off, but first-quarter results suffered because of it.
- Investor's Business Daily•5 hours ago
Vertex was the big winner Friday following a slew of biotechs and drugmakers issuing first-quarter reports Thursday.
- Motley Fool•6 hours ago
Biogen could struggle to maintain its market-leading position in multiple sclerosis over the next two years.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||123.77 x 200|
|Ask||124.17 x 200|
|Day's Range||123.20 - 124.30|
|52 Week Range||94.42 - 127.64|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||49.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|